Summary

Evelo Biosciences , Inc.

Founded in 2014

Description

Evelo is a clinical-stage biotech with a vision to dramatically improve healthcare. Our work aims to harness SINTAX to modulate the bodys immune system.

Strengths

  • Evelo Biosciences , Inc. has a strong market share in their industry
  • Revenue generated per employee is greater than industry average
  • Demonstrating revenue growth that is faster than the industry average
  • The number of employees is growing faster than the industry average
  • Since Evelo Biosciences , Inc. was founded, the company has grown faster than the industry average
  • Web traffic rankings are better than the industry average

Weaknesses

  • Variance of revenue growth is more than the industry average

Annual Revenue

Evelo Biosciences , Inc.'s annual revenue

$25783000

Based on Kona Equity data

  • Revenue per employee

    $211336

  • Variance of revenue growth

    86.05

  • Annual revenue growth since founding

    $2578300

  • Revenue growth rate from first known quarter to current

    75.5%

Employee Count

122 employees

  • Employee growth rate from first known quarter to current

    66.1%

Executives

Jacqueline Liu

Controller

j**@evelobio.com

Joseph Locke

Laboratory Technician & Research Associate

j**@evelobio.com

Naadim Chowdhury

Website Designer

n**@evelobio.com

Duncan Mchale

Chief Medical Officer

d**@evelobio.com

Olufemi Rabiu

Head Vice President, Quality

o**@evelobio.com

Mark Plinio

Chief Commercial Officer

m**@evelobio.com

Yusuf Akeel

Analytical Scientist

y**@evelobio.com

Mark Bodmer

Chief Scientific Officer

m**@evelobio.com

Jonathan Zung

Chief Development Officer

j**@evelobio.com

Kevin Huynh

Associate Scientist, Microbiology

k**@evelobio.com

Stephen Carriere

Vice President & Chief Accounting Officer

s**@evelobio.com

Joseph Shultz

Vice President, Bioprocess & Product Development

j**@evelobio.com

Leslie Wardwell-Scott

Vice President, Corporate Development

l**@evelobio.com

Edward English

Vice President & Corporate Controller

e**@evelobio.com

Tyler Rommel

Research Associate

t**@evelobio.com

Minerva Franco

Executive Assistant

m**@evelobio.com

Natalie Lissy

Vice President, Intellectual Property

n**@evelobio.com

Marella Thorell

Chief Financial Officer

m**@evelobio.com

Thomas Duplisea

Senior Accountant

t**@evelobio.com

Julie Carretero

Chief People Officer

j**@evelobio.com

Pankaj Patel

Senior Manager, Process Analytics & QC

p**@evelobio.com

Amanda Fleury

Manager, Operations

a**@evelobio.com

Taylor Cormack

Senior Research Associate

t**@evelobio.com

James Keats

Senior Process Development Associate & Engineer

j**@evelobio.com

Phil Ball

Head Vice President, Program Management

p**@evelobio.com

Valeria Kravitz

Senior Research Associate

v**@evelobio.com

Jing Zhu

Scientist

j**@evelobio.com

Jeremy Trelstad

Senior Director, Human Resources

j**@evelobio.com

Ellen Stewart

Director, Clinical Data Management

e**@evelobio.com

Xiaoli Liu

Vice President, Finance

x**@evelobio.com

G Score - 6

The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.

  • G1 Revenue is greater than the industry median.
  • G2 Income per employee more than industry average.
  • G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
  • G4 Employee growth rate from the first known quarter to current is higher than the industry average.
  • G6 Annual revenue growth since founding is higher than the industry average.
  • G7 Website traffic rankings are better than the industry average

Web Analysis

  • Rank

    2.13 M

  • Page views per visitor

    1.0

Location

620 Memorial Dr. 5th Fl. 
Cambridge, MA  02139

Unlock unlimited leads

Get access to millions of contacts, companies, emails, and more!

Similar Companies

GlycoMimetics

glycomimetics.com
  • Founded in 2003
  • Location: Rockville, MD
  • Annual Revenue: $104.0K
  • Employees: 52
  • GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. GlycoMimetics is a late clinical stage biotechnology company discovering and developing glycobiology based therapies for cancers...

Magenta Therapeutics, Inc.

magentatx.com
  • Founded in 2015
  • Location: Cambridge, MA
  • Annual Revenue: $15.9M
  • Employees: 86
  • Magenta Therapeutics is a clinical-stage biotech developing therapeutics to curative power of stem cell transplants to more patients

Annexon Biosciences

annexonbio.com
  • Founded in 2011
  • Location: South San Francisco, CA
  • Annual Revenue: $20.6M
  • Employees: 63
  • Annexon Biosciences is a California-based healthcare company engaged in the research and development of novel disease modifying drugs for neurodegenerative disorders. They are focused on developing a new class of complement medicines for patients with ...

Alector, Inc.

alector.com
  • Founded in 2013
  • Location: South San Francisco, CA
  • Annual Revenue: $227.4M
  • Employees: 237
  • Alector Therapeutics is a biopharmaceutical company that develops therapies for the treatment of neurodegenerative diseases. They combine state-of-the-art antibody technology with recent discoveries in neuroimmunology and human genetics to develop nove...

SQZ Biotech

sqzbiotech.com
  • Founded in 2013
  • Location: Watertown, MA
  • Annual Revenue: $24.5M
  • Employees: 113
  • SQZ Biotech is a company founded out of the Massachusetts Institute of Technology (MIT). At SQZ we have developed a high-throughput platform - CellSqueeze - for simple and effective material delivery into cells.

Cabaletta Bio, Inc.

cabalettabio.com
  • Founded in 2017
  • Location: Philadelphia, PA
  • Annual Revenue: $11.4M
  • Employees: 56
  • Cabaletta Bio discovers and develops targeted cell therapy product candidates to potentially cure patients with autoimmune diseases. Learn about our CAAR T cell products.

Key Information

  • SIC: 87; 873
  • NAICS: 5417; 541
Disclaimer: These numbers are estimates and any other company information is based off our proprietary algorithms and by no means should be accepted as 100% factual. Kona Equity is in no way affiliated with Evelo Biosciences , Inc..

See similar companies

Frequently Asked Questions

Where is Evelo Biosciences , Inc. located?

Evelo Biosciences , Inc.'s headquarters are located at 620 Memorial Dr. 5th Fl.  Cambridge, MA  02139.


What is Evelo Biosciences , Inc.'s official website?

Evelo Biosciences , Inc.'s official website is evelobio.com


What is Evelo Biosciences , Inc.'s revenue?

Evelo Biosciences , Inc.'s annual revenue is $25.8 M.


What is Evelo Biosciences , Inc.'s SIC code?

Evelo Biosciences , Inc.'s SIC: 87; 873


What is Evelo Biosciences , Inc.'s NAICS code?

Evelo Biosciences , Inc.'s NAICS: 5417; 541.


How many employees does Evelo Biosciences , Inc.'s have?

Evelo Biosciences , Inc. has 122 employees


What industry does Evelo Biosciences , Inc. belong to?

Evelo Biosciences , Inc. is in the industry of Biotechnology.

Next step

Visitors review